EUVIMEDEUVIMED entdecken
Multizentrische Studie

Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects

Shugo Yajima, Soichiro Yoshida iD, Shohei Fukuda iD, Wei Chen, Hiroyuki Sato iD, Akihiro Hirakawa iD, Hiroshi Fukushima, Yoh Matsuoka, Yukio Kageyama, Hajime Tanaka iD, Masaharu Inoue, Noboru Numao und 7 weitere

International Journal of Urology · 2026-06 · 33 (6)

DOI: 10.1111/iju.70536 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, online erschienen am 08.06.2026. Verfasst von Shugo Yajima und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Cancer Center Hospital East, Chiba, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, C-Reactive Protein, Neutrophils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate inflammatory biomarkers (neutrophil‐to‐lymphocyte ratio [NLR], C‐reactive protein [CRP]) as continuous variables and assess linearity and the proportional hazards (PH) assumption, including time‐varying effects, in metastatic renal cell carcinoma (mRCC) treated with first‐line immune checkpoint inhibitor (ICI)‐based combinations.

Methods

This multicenter retrospective study included 151 patients with mRCC. Log‐transformed NLR and CRP were tested for linearity (quadratic terms) and PH (Schoenfeld residuals). Multivariable Cox regression was adjusted for International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk factor count and treatment regimen. Time‐varying effects were assessed using marker × log(time) interactions and 12‐month landmark analyses; incremental discrimination beyond IMDC was evaluated using Harrell's concordance index.

Results

Log‐transformed NLR and CRP showed no statistically significant evidence of nonlinearity ( p = 0.211 and p = 0.055, respectively). NLR showed evidence of PH violation for all outcomes, whereas CRP did not. On multivariable analysis, NLR remained associated with overall survival (OS; adjusted hazard ratio [HR] 2.10, 95% confidence interval 1.26–3.49, p = 0.005) and cancer‐specific survival (adjusted HR 2.04, 1.20–3.47, p = 0.009). Landmark analysis suggested a stronger OS association during 0–12 months (HR 2.61, 1.49–4.59) than after 12 months (0.93, 0.37–2.34). Adding NLR to IMDC modestly improved OS discrimination (ΔC‐index +0.038, bootstrap p = 0.052).

Conclusions

Log‐transformed inflammatory markers showed no statistically significant evidence of nonlinearity. NLR showed exploratory evidence of time‐varying prognostic associations, with stronger discrimination during earlier follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsC-Reactive ProteinNeutrophilsHumansRetrospective StudiesPrognosisFemaleMaleProportional Hazards ModelsMiddle AgedAgedLymphocytesLymphocyte CountBiomarkers, Tumor

Stichwörter der Autor:innen

C‐reactive proteinlinearityneutrophil‐to‐lymphocyte ratioproportional hazardsrenal cell carcinoma

Substanzen

C-Reactive ProteinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, National Cancer Center Hospital East, Chiba, Japan.
  • Department of Urology, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
  • Department of Urology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.

ORCID-Profile: Soichiro Yoshida, Shohei Fukuda, Hiroyuki Sato, Akihiro Hirakawa, Hajime Tanaka, Akinori Nakayama, Kazutaka Saito, Masaya Ito, Fumitaka Koga

Zitieren

APA

Yajima, S., Yoshida, S., Fukuda, S., Chen, W., Sato, H., Hirakawa, A., Fukushima, H., Matsuoka, Y., Kageyama, Y., Tanaka, H., Inoue, M., Numao, N., Yonese, J., Nakayama, A., Saito, K., Ito, M., Koga, F., Masuda, H., & Fujii, Y. (2026). Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects. International Journal of Urology, 33(6). https://doi.org/10.1111/iju.70536

Vancouver

Yajima S, Yoshida S, Fukuda S, Chen W, Sato H, Hirakawa A, et al. Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects. International Journal of Urology. 2026;33(6). doi:10.1111/iju.70536

BibTeX
@article{Yajima2026,
  author = {Yajima, Shugo and Yoshida, Soichiro and Fukuda, Shohei and Chen, Wei and Sato, Hiroyuki and Hirakawa, Akihiro and Fukushima, Hiroshi and Matsuoka, Yoh and Kageyama, Yukio and Tanaka, Hajime and Inoue, Masaharu and Numao, Noboru and Yonese, Junji and Nakayama, Akinori and Saito, Kazutaka and Ito, Masaya and Koga, Fumitaka and Masuda, Hitoshi and Fujii, Yasuhisa},
  title = {Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects},
  journal = {International Journal of Urology},
  year = {2026},
  volume = {33},
  number = {6},
  doi = {10.1111/iju.70536}
}
Kostenlos starten →